Company Overview of Transplant Genomics, Inc.
Transplant Genomics, Inc., a molecular diagnostic company, develops molecular diagnostic tests that detect early signs of graft injury, differentiate among actionable causes, and enable optimization of therapy. It focuses on improving organ transplant outcomes. The company was founded in 2013 and is based in Brookline, Massachusetts.
1501 Beacon Street
Brookline, MA 02446
Founded in 2013
Key Executives for Transplant Genomics, Inc.
Transplant Genomics, Inc. Key Developments
Similar Private Companies By Industry
|SynerGene Therapeutics, Inc.||United States|
|Vet Therapeutics, Inc.||United States|
|Avid Radiopharmaceuticals, Inc.||United States|
|NanoInjection Technologies, LLC||United States|
|IDUN Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
November 24, 2014
To contact Transplant Genomics, Inc., please visit www.transplantgenomics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.